| Health / Medical Topics |
GVAX Pancreatic Cancer Vaccine
An irradiated, autologous pancreatic cancer vaccine consisting of patient-specific pancreatic cancer cells genetically modified to secrete the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Upon vaccination, GVAX pancreatic cancer vaccine secretes GM-CSF. In turn, GM-CSF may stimulate the body's immune system against tumor cells by enhancing the activation of dendritic cells (DCs) and promoting antigen presentation to both B- and T-cells. In addition, GM-CSF promotes antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function. (NCI Thesaurus)
YOU MAY ALSO LIKE
An autologous lung cancer vaccine consisting of patient-specific lung cancer cells genetically modified to secrete granulocyte-macrophage colony stimulating factor (GM-CSF), an immunostimulatory…
GVAX cancer vaccines are autologous cell vaccines comprised of tumor cells which have been irradiated and genetically modified to secrete granulocyte-macrophage colony…
Antineoplastic vaccine being developed against liver cancer.
A country in northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.
A quassinoid phytochemical isolated from the plant Simaba guianensis with potential antineoplastic and antimalarial activities.
A type of smokeless tobacco that is made in India and is widely used throughout Asia. It is a mixture of tobacco,…
